These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8200317)

  • 21. Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.
    Cox JL; Gotlieb AI
    CMAJ; 1986 May; 134(10):1129-32. PubMed ID: 2938706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gene therapy for the treatment of restenosis after coronary angioplasty].
    Rapacciuolo A; Indolfi C; Di Lorenzo E; Esposito G; Stabile E; Stingone AM; Avvedimento EV; Condorelli M; Chiariello M
    Cardiologia; 1994 Dec; 39(12):843-7. PubMed ID: 7781002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological observations late (greater than 30 days) after clinically successful coronary balloon angioplasty.
    Waller BF; Pinkerton CA; Orr CM; Slack JD; VanTassel JW; Peters T
    Circulation; 1991 Feb; 83(2 Suppl):I28-41. PubMed ID: 1991400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine: persistent benefit at 6-month follow-up.
    Wiedermann JG; Marboe C; Amols H; Schwartz A; Weinberger J
    J Am Coll Cardiol; 1995 May; 25(6):1451-6. PubMed ID: 7722148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pathogenesis of graft vascular disease: implications of vascular remodeling.
    Gibbons GH
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S149-58. PubMed ID: 8719477
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pathological mechanisms of restenosis after angioplasty. Cell and molecular biology findings--possible new therapeutic approaches].
    Bauriedel G
    Fortschr Med; 1994 Aug; 112(24):322-3. PubMed ID: 7959499
    [No Abstract]   [Full Text] [Related]  

  • 27. Predicting the likelihood of postangioplastic restenosis: a proliferating challenge for nuclear medicine.
    Narula J; Strauss HW
    J Nucl Med; 2000 Sep; 41(9):1541-4. PubMed ID: 10994736
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic strategies in the control of restenosis after angioplasty.
    McEwan JR
    Exp Nephrol; 1994; 2(2):92. PubMed ID: 8082020
    [No Abstract]   [Full Text] [Related]  

  • 29. [Coronary circulation-derived plasma in patients with vascular restenosis stimulates the growth of coronary artery smooth muscle cells in culture].
    Okamoto Y; Uemura S; Yamamoto H; Dohi K; Nakano H
    Rinsho Byori; 1997 Oct; 45(10):1008-12. PubMed ID: 9369081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What does pathology teach us about recurrent stenosis after coronary angioplasty?
    Hollman J
    J Am Coll Cardiol; 1991 Feb; 17(2):440-1. PubMed ID: 1991901
    [No Abstract]   [Full Text] [Related]  

  • 31. Growth factors and vascular smooth muscle cell growth responses.
    Delafontaine P
    Eur Heart J; 1998 Jul; 19 Suppl G():G18-22. PubMed ID: 9717051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Initial result of Gianturco-Roubin coronary stent].
    Tateyama H; Katoh O; Kobayashi T; Shibata N
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):954-60. PubMed ID: 12436644
    [No Abstract]   [Full Text] [Related]  

  • 33. A cascade model for restenosis. A special case of atherosclerosis progression.
    Libby P; Schwartz D; Brogi E; Tanaka H; Clinton SK
    Circulation; 1992 Dec; 86(6 Suppl):III47-52. PubMed ID: 1424051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is interleukin-1 beta a triggering factor for restenosis?
    Oemar BS
    Cardiovasc Res; 1999 Oct; 44(1):17-9. PubMed ID: 10615386
    [No Abstract]   [Full Text] [Related]  

  • 35. [Restenosis after percutaneous transluminal coronary angioplasty].
    Aschermann M
    Cas Lek Cesk; 1990 Apr; 129(17):513-5. PubMed ID: 2350767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restenosis after percutaneous transluminal coronary angioplasty: new therapeutic insights from pathogenic mechanisms.
    Berk BC; Harris K
    Adv Intern Med; 1995; 40():445-501. PubMed ID: 7747655
    [No Abstract]   [Full Text] [Related]  

  • 37. [Restenosis after coronary angioplasty. Contribution of experimental models].
    Bauters C; Hamon M; Van Belle E; Dupuis B; Lablanche JM; Bertrand ME
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():47-56. PubMed ID: 8215780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group.
    Verin V; Popowski Y; de Bruyne B; Baumgart D; Sauerwein W; Lins M; Kovacs G; Thomas M; Calman F; Disco C; Serruys PW; Wijns W;
    N Engl J Med; 2001 Jan; 344(4):243-9. PubMed ID: 11172150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The incidence and mechanism of restenosis after PTCA].
    Nagai T; Mizuno K
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):856-62. PubMed ID: 12436628
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospects for prevention of graft stenosis and angioplasty restenosis.
    Chan P
    Eur J Vasc Endovasc Surg; 1997 May; 13(5):429-31. PubMed ID: 9166263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.